Nicole Mayer-Hamblett

Also affiliated with Cystic Fibrosis Foundation, Seattle Children's Hospital, Pediatrics and Genetics, Seattle University

MedicineBiochemistry, Genetics and Molecular BiologySocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials”.

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00434-9

N/A

3.9DataRank · unranked

127 citations

Félix Ratjen, Renee Russell, Scott H. Donaldson, Kristin A. Riekert, Gregory S. Sawicki +91 more

Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00324-7

N/A

0.604DataRank · unranked

55 citations

Susan E. Birket, John P. Clancy, D.G. Downey, John F. Engelhardt, Isabelle Fajac +8 more

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.05.011

N/A

0.520DataRank · unranked

31 citations

Silke van Koningsbruggen‐Rietschel, David P. Nichols, Donald R. VanDevanter, Jane C. Davies, T. Lee +20 more

The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.02.003

N/A

0.457DataRank · unranked

20 citations

Timothy E. Corcoran, Joseph M. Pilewski, Beth L. Laube, Peter J. Mogayzel, Agathe Ceppe +8 more

Willingness of people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor (ETI) to participate in randomized modulator and inhaled antimicrobial clinical trials

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.04.007

N/A

0.347DataRank · unranked

5 citations

Edith T. Zemanick, Michael W. Konstan, Clement L. Ren, Katherine Odem‐Davis, I. Emerman +3 more

A new path for CF clinical trials through the use of historical controls

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.11.007

N/A

0DataRank · unranked

6 citations

Mark N. Warden, Noah Simon, Sonya L. Heltshe, George Retsch‐Bogart, Bonnie W. Ramsey +2 more

Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial

ERJ Open Research(2022)10.1183/23120541.00190-2022

N/A

0DataRank · unranked

9 citations

Ellen Caldwell, Nicole Mayer-Hamblett, Christopher H. Goss, Marianne S. Muhlebach, F.M. Cunningham

Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new Pseudomonas

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.02.015

N/A

0DataRank · unranked

14 citations

M. Skalland, Scott D. Sagel, Bonnie W. Ramsey, Nicole Mayer-Hamblett, George Retsch‐Bogart +1 more

Development and Internal Validation of a Prognostic Model of the Probability of Death or Lung Transplantation Within 2 Years for Patients With Cystic Fibrosis and FEV1 ≤ 50% Predicted

CHEST Journal(2022)10.1016/j.chest.2022.05.021

N/A

0DataRank · unranked

8 citations

Travis Hee Wai, Anne L. Stephenson, Jenna Sykes, Sanja Stanojevic, Patricia J Rodriguez +5 more

Characterizing CFTR modulated sweat chloride response across the cf population: Initial results from the CHEC-SC study

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.07.008

N/A

0DataRank · unranked

8 citations

Edith T. Zemanick, Katherine Odem‐Davis, Donald R. VanDevanter, Mark N. Warden, Steven M. Rowe +4 more

Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation

Pulmonary Therapy(2022)10.1007/s41030-022-00202-y

N/A

0DataRank · unranked

4 citations

Michael W. Konstan, Edward F. McKone, Richard B. Moss, Barry Lubarsky, Ellison Suthoff +8 more

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00297-7

N/A

0DataRank · unranked

33 citations

John P. Clancy, Raksha Jain, Scott H. Donaldson, Isabelle Fajac, Christopher H. Goss +21 more

Potential implicit bias in attribution of adverse events in randomized controlled trials in cystic fibrosis

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.05.014

N/A

0DataRank · unranked

1 citations

Madeline Wessels, T. Milinic, Kathleen J. Ramos, Nicole Mayer-Hamblett, Bonnie W. Ramsey +4 more

Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis

Annals of the American Thoracic Society(2024)10.1513/annalsats.202404-366oc

N/A

0DataRank · unranked

10 citations

Alex H. Gifford, Margaret Kloster, Renee Russell, Andrew T. Braun, Ronald L. Gibson +11 more

Statistical approaches for the integration of external controls in a cystic fibrosis clinical trial: a simulation and an application

American Journal of Epidemiology(2024)10.1093/aje/kwae148

N/A

0DataRank · unranked

1 citations

Sonya L. Heltshe, Noah Simon, Stephen J. Mooney, Nicole Mayer-Hamblett, Amalia Magaret +1 more

PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.07.015

N/A

0DataRank · unranked

17 citations

Dara Riva, Yair J. Blumenfeld, John F. Engelhardt, Carmen Luna‐Paredes, Carlos Milla +17 more

Real-world association between ivacaftor initiation and lung function variability: A registry study

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.01.014

N/A

0DataRank · unranked

3 citations

Eleni-Rosalina Andrinopoulou, Hancheng Li, Raksha Jain, Nicole Mayer-Hamblett, Josh Ostrenga +7 more

Accelerated Approval or Risk Reduction? How Response Biomarkers Advance Therapeutics through Clinical Trials in Cystic Fibrosis

Trends in Molecular Medicine(2020)10.1016/j.molmed.2020.08.002

N/A

0DataRank · unranked

9 citations

Donald R. VanDevanter, Nicole Mayer-Hamblett

Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies after Rapid Adoption: A Dual-Approach Study

Annals of the American Thoracic Society(2025)10.1513/annalsats.202503-267oc

N/A

0DataRank · unranked

1 citations

Grace C Zhou, Weiji Su, Pierre-Régis Burgel, Elizabeth A. Cromwell, Christopher H. Goss +13 more

Long-term azithromycin use is not associated with QT prolongation in children with cystic fibrosis

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.11.005

N/A

0DataRank · unranked

7 citations

Jack C. Salerno, Jason F. Deen, Margaret Kloster, Nicole Mayer-Hamblett, Bonnie W. Ramsey +2 more

Real-world evidence in cystic fibrosis modulator development: Establishing a path forward

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.03.020

N/A

0DataRank · unranked

6 citations

Mark N. Warden, Noah Simon, Sonya L. Heltshe, Nicole Mayer-Hamblett, Amalia Magaret

Measuring the impact of CFTR modulation on sweat chloride in cystic fibrosis: Rationale and design of the CHEC-SC study

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.01.011

N/A

0DataRank · unranked

24 citations

Michael W. Konstan, Donald R. VanDevanter, Steven M. Rowe, JP Clancy, Katherine Odem‐Davis +3 more

Validation of the French 3-year prognostic score for death or lung transplant in the United States cystic fibrosis population

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.08.008

N/A

0DataRank · unranked

9 citations

Travis Hee Wai, Jenna Sykes, Xiayi Ma, Anne L. Stephenson, Ann L. Jennerich +4 more